Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Cytokinetics granted stock options to purchase 52,834 shares and 35,025 restricted stock units to 23 new employees as material inducements to employment under Nasdaq Listing Rule 5635(c)(4). The options carry a $69.31 exercise price, equal to the September 15, 2026 closing price, a 10-year term, and four-year vesting; the RSUs vest over three years on a 40%/40%/20% schedule.
Key figures
- Rsu count
- 35025
- Grant date
- 2026-09-15
- Employees granted
- 23
- Option term years
- 10
- Rsu vest schedule
- 3 years (40%/40%/20% at each anniversary)
- Stock option shares
- 52834
- Option vest schedule
- 4 years (25% at 1-year anniversary, remainder monthly over 36 months)
- Option exercise price
- 69.31
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.